Supplementary Data from Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Autor:	Hagop Kantarjian, Padmanee Sharma, James P. Allison, Jorge Blando, Keyur P. Patel, Jeffrey L. Jorgensen, Carlos Bueso-Ramos, Zainab Alhamal, Wilmer Flores, Steven M. Kornblau, Tauna Gordon, Sherry A. Pierce, Michael Andreeff, Courtney D. DiNardo, Naveen Pemmaraju, Jing Ning, Graciela M. Nogueras-Gonzalez, Tapan Kadia, Elias Jabbour, Farhad Ravandi-Kashani, Marina Konopleva, Jorge E. Cortes, Mansour Alfayez, Prajwal C. Boddu, Sreyashi Basu, Guillermo Garcia-Manero, Naval Daver
Rok vydání:	2023
DOI:	10.1158/2159-8290.22532990
Popis:	Supplement (adjusted per last reviewer comment).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee191782a4e9799f5f8dbba012c1019 https://doi.org/10.1158/2159-8290.22532990 Zobrazit plný text záznamu